CP
Corvus Pharmaceuticals Inc
🇺🇸XNAS.CRVSUnited StatesHealthcare
$12.24USDdown -0.72 (-5.56%)ClosedDelayed11:25 PM
Price$12.24-0.72 (-5.56%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US2210151005
- CUSIP
- 221015100
Company
- Employees
- 37
- Headquarters
- South San Francisco, United States
- Website
- https://www.corvuspharma.com
- CEO
- Dr. Richard A. Miller M.D.
Market
- Shares outstanding
- 84.1M
- Market cap
- $1.03B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $1.09B
- EPS LTM
- -$0.64calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -19.02calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$54.13M-19.93%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$45.23M-56.09%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.